Personalized treatment of malignant mesothelioma-dream or reality?
作者信息
Roden Anja C
机构信息
Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN, USA.
出版信息
J Thorac Dis. 2018 Jul;10(Suppl 18):S2153-S2156. doi: 10.21037/jtd.2018.06.67.
Abstract
摘要
相似文献
1
Personalized treatment of malignant mesothelioma-dream or reality?恶性间皮瘤的个性化治疗——梦想还是现实？
J Thorac Dis. 2018 Jul;10(Suppl 18):S2153-S2156. doi: 10.21037/jtd.2018.06.67.
2
Personalized medicine: elusive dream or imminent reality?个性化医疗：难以实现的梦想还是即将到来的现实？
Clin Pharmacol Ther. 2007 Jun;81(6):807-16. doi: 10.1038/sj.clpt.6100204.
3
"Personalized medicine: elusive dream or imminent reality?": A commentary.“个性化医疗：遥不可及的梦想还是即将到来的现实？”：一篇评论
Clin Pharmacol Ther. 2007 Jun;81(6):801-5. doi: 10.1038/sj.clpt.6100227.
4
Advances in the biology of malignant pleural mesothelioma.恶性胸膜间皮瘤的生物学进展。
Cancer Treat Rev. 2011 Nov;37(7):543-58. doi: 10.1016/j.ctrv.2011.01.001. Epub 2011 Feb 1.
5
Personalized therapy for breast cancer: a dream or a reality?乳腺癌的个体化治疗：梦想还是现实？
Future Oncol. 2013 Aug;9(8):1105-19. doi: 10.2217/fon.13.57.
6
Personalized pain medicine: pipe dream or reality?个性化疼痛医学：白日梦还是现实？
Anesthesiology. 2015 May;122(5):967-8. doi: 10.1097/ALN.0000000000000638.
7
Dream-reality confusion in borderline personality disorder: a theoretical analysis.边缘型人格障碍中的梦境与现实混淆：理论分析
Front Psychol. 2015 Sep 15;6:1393. doi: 10.3389/fpsyg.2015.01393. eCollection 2015.
8
The 'mad scientists': psychoanalysis, dream and virtual reality.“疯狂科学家”：精神分析、梦境与虚拟现实。
Int J Psychoanal. 2003 Apr;84(Pt 2):331-46. doi: 10.1516/002075703321632766.
9
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.用载药细菌纳米细胞靶向间皮素受体可抑制小鼠异种移植模型中的人恶性间皮瘤肿瘤生长。
PLoS One. 2017 Oct 23;12(10):e0186137. doi: 10.1371/journal.pone.0186137. eCollection 2017.
10
Dreams within dreams.梦中梦。
Psychoanal Study Child. 2002;57:118-30. doi: 10.1080/00797308.2002.11800688.
引用本文的文献
1
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma.泽兰诱导的代谢重编程抑制间皮瘤中的 YAP/TAZ/TEAD 致癌轴。
J Exp Clin Cancer Res. 2019 Aug 9;38(1):349. doi: 10.1186/s13046-019-1352-3.
本文引用的文献
1
Progress in the Management of Malignant Pleural Mesothelioma in 2017.2017 年恶性胸膜间皮瘤治疗进展。
J Thorac Oncol. 2018 May;13(5):606-623. doi: 10.1016/j.jtho.2018.02.021. Epub 2018 Mar 8.
2
Novel therapies for malignant pleural mesothelioma.恶性胸膜间皮瘤的新型治疗方法。
Lancet Oncol. 2018 Mar;19(3):e161-e172. doi: 10.1016/S1470-2045(18)30100-1.
3
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.抑癌基因 BAP1 功能丧失会增强癌细胞对 TRAIL 的敏感性。
Elife. 2018 Jan 18;7:e30224. doi: 10.7554/eLife.30224.
4
Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.BAP1 表达缺失有助于预测恶性间皮瘤的非典型间皮增生。
Am J Surg Pathol. 2018 Feb;42(2):256-263. doi: 10.1097/PAS.0000000000000976.
5
Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.全面的恶性胸膜间皮瘤药物基因组分析确定了对 FGFR 抑制敏感的亚组。
Clin Cancer Res. 2018 Jan 1;24(1):84-94. doi: 10.1158/1078-0432.CCR-17-1172. Epub 2017 Oct 23.
6
Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.鉴定恶性腹膜间皮瘤中的 ALK 重排。
JAMA Oncol. 2018 Feb 1;4(2):235-238. doi: 10.1001/jamaoncol.2017.2918.
7
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.聚乙二醇化精氨酸脱亚氨酶、顺铂和培美曲塞用于精氨琥珀酸合成酶1缺乏的胸段癌症患者的1期剂量递增研究。
J Clin Oncol. 2017 Jun 1;35(16):1778-1785. doi: 10.1200/JCO.2016.71.3230. Epub 2017 Apr 7.
8
Malignant Mesothelioma Mortality - United States, 1999-2015.美国1999 - 2015年恶性间皮瘤死亡率
MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):214-218. doi: 10.15585/mmwr.mm6608a3.
9
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.精氨酸剥夺联合聚乙二醇化精氨酸脱亚氨酶治疗精氨酸合成酶 1 缺陷型恶性胸膜间皮瘤的随机临床试验。
JAMA Oncol. 2017 Jan 1;3(1):58-66. doi: 10.1001/jamaoncol.2016.3049.
10
BRCA1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: A Large Retrospective Study.BRCA1 相关蛋白 1（BAP1）免疫组织化学表达作为恶性胸膜间皮瘤分类的诊断工具：一项大型回顾性研究。
J Thorac Oncol. 2016 Nov;11(11):2006-2017. doi: 10.1016/j.jtho.2016.06.020. Epub 2016 Jul 13.
Zotero 插件